{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:11:14Z","timestamp":1793722274736,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874368"],"award-info":[{"award-number":["81874368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630100"],"award-info":[{"award-number":["81630100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z181100006218001"],"award-info":[{"award-number":["Z181100006218001"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX09301022"],"award-info":[{"award-number":["2017ZX09301022"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epimedii Folium (EF) is commonly used for treating bone fractures and joint diseases, but the potential hepatotoxicity of EF limits its clinical application. Our previous study confirms that EF could lead to idiosyncratic drug-induced liver injury (IDILI) and hepatocyte apoptosis, but the mechanism remains unknown. Studies have shown that NLRP3 inflammasome plays an important role in the development of various inflammatory diseases such as IDILI. Specific stimulus-induced NLRP3 inflammasome activation may has been a key strategy for lead to liver injury. Therefore, main compounds derived from EF were chosen to test whether the ingredients in EF could activate the NLRP3 inflammasome and to induce IDILI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bone-marrow-derived macrophages (BMDMs) were treated with Icariside I, and then stimulated with inflammasome stimuli and assayed for the production of caspase-1 and interleukin 1\u03b2 (IL-1\u03b2) and the release of lactate dehydrogenase (LDH). Determination of intracellular potassium, ASC oligomerization as well as reactive oxygen species (ROS) production were used to evaluate the stimulative mechanism of Icariside I on inflammasome activation. Mouse models of NLRP3 diseases were used to test whether Icariside I has hepatocyte apoptosis effects and promoted NLRP3 inflammasome activation in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Icariside I specifically enhances NLRP3 inflammasome activation triggered by ATP or nigericin but not SiO2, poly(I:C) or cytosolic LPS. Additionally, Icariside I does not alter the activation of NLRC4 and AIM2 inflammasomes. Mechanically, Icariside I alone does not induce mitochondrial reactive oxygen species (mtROS), which is one of the critical upstream events of NLRP3 inflammasome activation; however, Icariside I increases mtROS production induced by ATP or nigericin but not SiO2. Importantly, Icariside I leads to liver injury and NLRP3 inflammasome activation in an LPS-mediated susceptibility mouse model of IDILI, but the effect of Icariside I is absent in the LPS-mediated mouse model pretreated with MCC950, which is used to mimic knockdown of NLRP3 inflammasome activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study reveals that Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity. The findings suggest that Icariside I or EF should be avoided in patients with diseases related to ATP or nigericin-induced NLRP3 inflammasome activation, which may be risk factors for IDILI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-020-00647-1","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:04:01Z","timestamp":1613045041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"647_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","volume":"146","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914\u201328.","journal-title":"Gastroenterology"},{"key":"647_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fphar.2019.00837","volume":"10","author":"J Uetrecht","year":"2019","unstructured":"Uetrecht J. Mechanistic Studies of Idiosyncratic DILI: Clinical Implications. Front Pharmacol. 2019;10:837.","journal-title":"Front Pharmacol"},{"key":"647_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.apha.2018.12.001","volume":"85","author":"J Uetrecht","year":"2019","unstructured":"Uetrecht J. Mechanisms of idiosyncratic drug-induced liver injury. Adv Pharmacol. 2019;85:133\u201363.","journal-title":"Adv Pharmacol"},{"key":"647_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3109\/10408444.2011.575765","volume":"41","author":"RA Roth","year":"2011","unstructured":"Roth RA, Ganey PE. Animal models of idiosyncratic drug-induced liver injury--current status. Crit Rev Toxicol. 2011;41:723\u201339.","journal-title":"Crit Rev Toxicol"},{"key":"647_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","volume":"66","author":"GA Kullak-Ublick","year":"2017","unstructured":"Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut. 2017;66:1154\u201364.","journal-title":"Gut"},{"key":"647_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","volume":"30","author":"T Cho","year":"2017","unstructured":"Cho T, Uetrecht J. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction. Chem Res Toxicol. 2017;30:295\u2013314.","journal-title":"Chem Res Toxicol"},{"key":"647_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/toxsci\/kfp163","volume":"111","author":"PJ Shaw","year":"2009","unstructured":"Shaw PJ, Beggs KM, Sparkenbaugh EM, Dugan CM, Ganey PE, Roth RA. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. Toxicol Sci. 2009;111:288\u2013301.","journal-title":"Toxicol Sci"},{"key":"647_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/jpet.114.214189","volume":"350","author":"KL Poulsen","year":"2014","unstructured":"Poulsen KL, Olivero-Verbel J. Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-alpha by macrophages: role of the DNA damage response. J Pharmacol Exp Ther. 2014;350:164\u201370.","journal-title":"J Pharmacol Exp Ther"},{"key":"647_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.taap.2012.11.030","volume":"266","author":"A Gandhi","year":"2013","unstructured":"Gandhi A, Guo T, Shah P, Moorthy B, Ghose R. Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice. Toxicol Appl Pharmacol. 2013;266:430\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"key":"647_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.27549","volume":"61","author":"IG Metushi","year":"2015","unstructured":"Metushi IG, Hayes MA, Uetrecht J. Treatment of PD-1(\u2212\/\u2212) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology. 2015;61:1332\u201342.","journal-title":"Hepatology."},{"key":"647_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019;156:2230\u201341.e11.","journal-title":"Gastroenterology"},{"key":"647_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2014.11.009","volume":"159","author":"L Lin","year":"2015","unstructured":"Lin L, Ni B, Lin H, Zhang M, Li X, Yin X, Qu C, Ni J. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol. 2015;159:158\u201383.","journal-title":"J Ethnopharmacol"},{"key":"647_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphar.2019.00335","volume":"10","author":"C Tu","year":"2019","unstructured":"Tu C, He Q, Li CY, Niu M, Han ZX, Ge FL, et al. Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats. Front Pharmacol. 2019;10:335.","journal-title":"Front Pharmacol"},{"issue":"1","key":"647_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11684-019-0690-z","volume":"14","author":"Y Gao","year":"2020","unstructured":"Gao Y, Wang Z, Tang J, Liu X, Shi W, Qin N, et al. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus inducesidiosyncratic hepatotoxicity under immunological stress conditions. Front Med. 2020;14(1):68\u201380. https:\/\/doi.org\/10.1007\/s11684-019-0690-z.","journal-title":"Front Med."},{"key":"647_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jep.2014.10.027","volume":"158 Pt A","author":"L Wang","year":"2014","unstructured":"Wang L, Li Z, Li L, Li Y, Yu M, Zhou Y, Lv X, Arai H, Xu Y. Acute and sub-chronic oral toxicity profiles of the aqueous extract of Cortex Dictamni in mice and rats. J Ethnopharmacol. 2014;158 Pt A:207\u201315.","journal-title":"J Ethnopharmacol"},{"key":"647_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821\u201332.","journal-title":"Cell"},{"key":"647_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","volume":"265","author":"EI Elliott","year":"2015","unstructured":"Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265:35\u201352.","journal-title":"Immunol Rev"},{"key":"647_CR18","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3389\/fimmu.2017.01728","volume":"8","author":"X Wu","year":"2017","unstructured":"Wu X, Dong L, Lin X, Li J. Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease. Front Immunol. 2017;8:1728.","journal-title":"Front Immunol"},{"key":"647_CR19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","volume":"57","author":"G Szabo","year":"2012","unstructured":"Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol. 2012;57:642\u201354.","journal-title":"J Hepatol"},{"key":"647_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2228","volume":"13","author":"H Wen","year":"2012","unstructured":"Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol. 2012;13:352\u20137.","journal-title":"Nat Immunol"},{"key":"647_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jep.2011.01.001","volume":"134","author":"H Ma","year":"2011","unstructured":"Ma H, He X, Yang Y, Li M, Hao D, Jia Z. The genus Epimedium: an ethnopharmacological and phytochemical review. J Ethnopharmacol. 2011;134:519\u201341.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"647_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/molecules24071263","volume":"24","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang T, Zhao BS, Zhang JX, Yang S, Fan CL, Li P. Effect of 2\u2033-O-Rhamnosyl Icariside II, Baohuoside I and Baohuoside II in Herba Epimedii on Cytotoxicity Indices in HL-7702 and HepG2 Cells. Molecules. 2019;24(7):1263. https:\/\/doi.org\/10.3390\/molecules24071263.","journal-title":"Molecules."},{"key":"647_CR23","first-page":"3745051","volume":"2019","author":"R Zhong","year":"2019","unstructured":"Zhong R, Chen Y, Ling J, Xia Z, Zhan Y, Sun E, Shi Z, Feng L. The Toxicity and Metabolism Properties of Herba Epimedii Flavonoids on Laval and Adult Zebrafish. Evid Based Complement Alternat Med. 2019;2019:3745051.","journal-title":"Evid Based Complement Alternat Med"},{"key":"647_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2019.02.003","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, et al. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm Sin B. 2019;9:734\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"647_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","volume":"68","author":"N Song","year":"2017","unstructured":"Song N, Liu ZS, Xue W, Bai ZF, Wang QY, Dai J, et al. NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. Mol Cell. 2017;68:185\u201397.e6.","journal-title":"Mol Cell"},{"key":"647_CR26","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","volume":"9","author":"H He","year":"2018","unstructured":"He H, Jiang H, Chen Y, Ye J, Wang A, Wang C. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9:2550.","journal-title":"Nat Commun"},{"key":"647_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"647_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","volume":"63","author":"M Chen","year":"2015","unstructured":"Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol. 2015;63:503\u201314.","journal-title":"J Hepatol"},{"key":"647_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ajg.2014.131","volume":"109","author":"NP Chalasani","year":"2014","unstructured":"Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109:950\u201366 quiz 67.","journal-title":"Am J Gastroenterol"},{"key":"647_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bjornsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65:363\u201373.","journal-title":"Hepatology."},{"key":"647_CR31","first-page":"2017","volume":"9176937","author":"AD Roth","year":"2017","unstructured":"Roth AD, Lee MY. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. Biomed Res Int. 2017;9176937:2017.","journal-title":"Biomed Res Int"},{"key":"647_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","volume":"92","author":"A Wree","year":"2014","unstructured":"Wree A, McGeough MD, Pena CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl). 2014;92:1069\u201382.","journal-title":"J Mol Med (Berl)"},{"key":"647_CR33","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122:3476\u201389.","journal-title":"J Clin Invest"},{"key":"647_CR34","doi-asserted-by":"publisher","first-page":"e56100","DOI":"10.1371\/journal.pone.0056100","volume":"8","author":"LJ Dixon","year":"2013","unstructured":"Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One. 2013;8:e56100.","journal-title":"PLoS One"},{"key":"647_CR35","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acs.chemrestox.7b00065","volume":"30","author":"R Kato","year":"2017","unstructured":"Kato R, Uetrecht J. Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes. Chem Res Toxicol. 2017;30:1327\u201332.","journal-title":"Chem Res Toxicol"},{"key":"647_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2019.11.100","volume":"522","author":"DK Dwivedi","year":"2020","unstructured":"Dwivedi DK, Jena GB. Diethylnitrosamine and thioacetamide-induced hepatic damage and early carcinogenesis in rats: Role of Nrf2 activator dimethyl fumarate and NLRP3 inhibitor glibenclamide. Biochem Biophys Res Commun. 2020;522:381\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"647_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cbi.2019.01.029","volume":"302","author":"ME Mostafa","year":"2019","unstructured":"Mostafa ME, Shaaban AA, Salem HA. Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride. Chem Biol Interact. 2019;302:53\u201360.","journal-title":"Chem Biol Interact"},{"key":"647_CR38","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00210-018-1540-2","volume":"391","author":"DK Dwivedi","year":"2018","unstructured":"Dwivedi DK, Jena GB. Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation. Naunyn Schmiedeberg's Arch Pharmacol. 2018;391:1257\u201374.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00647-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-020-00647-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00647-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T15:15:16Z","timestamp":1675178116000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-020-00647-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/s12964-020-00647-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17931\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17931\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17931\/v3","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"23 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest to disclose. The study was approved by the Experimental Animal Center of Chinese PLA General Hospital, Beijing, China. All procedures followed were in accordance with the ethical standards of the Ethics Committee of the Chinese PLA General Hospital and the Helsinki Declaration of 1975.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}